Stoke Therapeutics, Inc.
STOK
31 insider filings · Latest: Jun 16, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Aug 29, 2025 | Aug 29 8:17 PM | JONATHAN ALLAN | Proposed Sale | 22,117 | $19.77 | $437.3K | — | View → |
| Aug 13, 2025 | Aug 13 8:29 PM | JONATHAN ALLAN | Proposed Sale | 13,712 | $13.53 | $185.5K | — | View → |
| Jul 1, 2025 | Jul 1 8:27 PM | BARUCH TICHO | Proposed Sale | 9,007 | $11.35 | $102.2K | — | View → |
| May 1, 2025 | May 1 8:45 PM | BARUCH S. TICHO | Proposed Sale | 34,847 | $9.76 | $340.1K | — | View → |
| Dec 23, 2024 | Dec 23 11:15 PM | Blue Horizon Enterprise Ltd | Proposed Sale | 2,000,000 | $11.59 | $23.2M | — | View → |
| Dec 9, 2024 | Dec 9 9:48 PM | JONATHAN ALLAN | Proposed Sale | 12,114 | $13.27 | $160.8K | — | View → |
| Nov 1, 2024 | Nov 1 8:50 PM | BARUCH TICHO | Proposed Sale | 20,000 | $12.36 | $247.2K | — | View → |
| Sep 19, 2024 | Sep 19 9:23 PM | Blue Horizon E LTD | Proposed Sale | 1,937,500 | $15.22 | $29.5M | — | View → |
← Previous
Page 3 of 3
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 3, 2026 | Jun 5 8:33 PM | Arthur TzianabosDirector | Grant/Award | 17,786 | $29.46 | 17,786(D) | View → |
| Jun 3, 2026 | Jun 5 8:31 PM | Julie SmithDirector | Grant/Award | 17,786 | $29.46 | 17,786(D) | View → |
| Jun 3, 2026 | Jun 5 8:30 PM | LEVIN ARTHUR ADirector | Grant/Award | 17,786 | $29.46 | 17,786(D) | View → |
| Jun 3, 2026 | Jun 5 8:29 PM | Adrian R. KrainerDirector | Grant/Award | 17,786 | $29.46 | 17,786(D) | View → |
| Jun 3, 2026 | Jun 5 8:27 PM | Edward M. Kaye MDDirector | Grant/Award | 17,786 | $29.46 | 17,786(D) | View → |
| Jun 3, 2026 | Jun 5 8:26 PM | Seth Loring HarrisonDirector | Grant/Award | 17,786 | $29.46 | 17,786(D) | View → |
| Jun 3, 2026 | Jun 5 8:24 PM | Jennifer BursteinDirector | Grant/Award | 17,786 | $29.46 | 17,786(D) | View → |
| Apr 3, 2026 | Apr 7 11:09 PM | Clare KahnDirector | Grant/Award | 30,782 | $32.79 | 30,782(D) | View → |
| Mar 19, 2026 | Mar 19 10:01 PM | Barry TichoCHIEF MEDICAL OFFICER | Option Exercise | 1,365 | $2.19 | 83,035(D) | View → |
| Mar 15, 2026 | Mar 17 9:26 PM | Jason HoittChief Patient Officer | Option Exercise | 10,000 | — | 30,000(D) | View → |
| Mar 15, 2026 | Mar 17 9:26 PM | Thomas LeggettChief Financial Officer | Option Exercise | 14,750 | — | 44,250(D) | View → |
| Mar 15, 2026 | Mar 17 9:25 PM | Barry TichoCHIEF MEDICAL OFFICER | Option Exercise | 33,850 | — | 32,250(D) | View → |
| Mar 15, 2026 | Mar 17 9:24 PM | Edward M. Kaye MDDirector | Option Exercise | 61,750 | — | 52,500(D) | View → |
| Mar 15, 2026 | Mar 17 9:23 PM | Jonathan AllanGENERAL COUNSEL & CORP SEC | Option Exercise | 25,475 | — | 36,000(D) | View → |
| Mar 10, 2026 | Mar 12 8:57 PM | Arthur TzianabosDirector, Interim Executive Chair | Option Exercise | 3,955 | $8.33 | 118,696(D) | View → |
| Feb 17, 2026 | Feb 19 9:25 PM | Barry TichoCHIEF MEDICAL OFFICER | Grant/Award | 100,000 | $31.09 | 40,000(D) | View → |
| Feb 17, 2026 | Feb 19 9:24 PM | Ian F SmithDirector, Chief Executive Officer | Grant/Award | 322,000 | $31.09 | 129,000(D) | View → |
| Feb 17, 2026 | Feb 19 9:22 PM | Thomas LeggettChief Financial Officer | Grant/Award | 100,000 | $31.09 | 40,000(D) | View → |
| Feb 17, 2026 | Feb 19 9:21 PM | Jason HoittChief Patient Officer | Grant/Award | 120,000 | $31.09 | 48,000(D) | View → |
| Feb 17, 2026 | Feb 19 9:20 PM | Jonathan AllanGENERAL COUNSEL & CORP SEC | Grant/Award | 88,000 | $31.09 | 35,000(D) | View → |